Related Experiment Videos
Monosodium glutamate and asthma
1Division of Allergy, Asthma and Immunology, Scripps Clinic and the Scripps Research Institute, La Jolla, CA 92037, USA.
Abstract:
Allen et al. (1987) conducted oral monosodium glutamate (MSG) challenges with 32 asthmatic volunteers and reported that 14 reacted to MSG. Another study by Moneret-Vautrin (1987) also reported MSG-induced asthma attacks in 2 of 30 asthmatic patients. Four additional studies have been conducted and none has confirmed the results of the above authors. These studies, by Schwartzstein et al. (1987), Germano (1991), Woods et al. (1998) and Woessner et al. (1999), challenged a total of 45 patients who gave a history of asthma attacks in oriental restaurants. None of these patients experienced asthmatic reactions after ingesting MSG (one-sided confidence interval of 0-0.066). Another 109 asthmatic patients, without a history of asthma in oriental restaurants, also did not react to ingestion of MSG (one-sided confidence interval of 0-0.027). With a confidence interval < 0.05 there is a >95% probability that MSG history-negative asthmatic patients are not sensitive to MSG. For the MSG history-positive asthmatics, 45 patients, in well-performed studies, underwent negative challenges to MSG, contrasting with two studies reporting positive challenges. Allen et al. (1987) and Moneret-Vautrin (1987), who reported positive MSG challenge results, performed studies with the following characteristics: 1) single blinded, conducted after discontinuing essential antiasthma medications; 2) used effort-dependent peak expiratory flow rate measurement of lung function; 3) added AM bronchodilators in some patients; 4) ignored wandering baselines on the placebo challenge days; and 5) conducted some challenges in the AM and some at night. In summary, the existence of MSG-induced asthma, even in history-positive patients, has not been established conclusively.
Insights
Monosodium glutamate (MSG) challenges in asthmatic patients show inconsistent results. Rigorous studies indicate no conclusive evidence of MSG-induced asthma, even in those with a history of reactions.
Area of Science:
- Clinical Medicine
- Allergy and Immunology
- Pulmonary Medicine
Background:
- Monosodium glutamate (MSG) has been anecdotally linked to asthma exacerbations.
- Previous studies reported positive MSG challenges in asthmatic individuals.
Purpose of the Study:
- To evaluate the evidence for MSG-induced asthma.
- To critically assess studies reporting positive MSG challenges versus those with negative findings.
Main Methods:
- Review and analysis of existing studies on MSG challenges in asthmatic volunteers.
- Comparison of methodologies in studies reporting positive versus negative MSG challenge results.
- Statistical analysis including confidence intervals for MSG-naive and MSG-history-positive asthmatics.
Main Results:
- Two early studies reported positive MSG challenges, but four subsequent, more rigorous studies found no reactions in 45 MSG-history-positive asthmatics.
- No reactions were observed in 109 asthmatic patients without a history of MSG sensitivity.
- Methodological flaws were identified in the studies reporting positive MSG challenges.
Conclusions:
- The existence of MSG-induced asthma is not conclusively established, even in patients with a history of reactions.
- Methodological differences may explain discrepancies in study outcomes.
- Further high-quality research is needed to definitively ascertain the role of MSG in asthma.